Literature DB >> 23769941

Chronic kidney disease and the short-term risk of mortality and amputation in patients hospitalized for peripheral artery disease.

Philippe Lacroix1, Victor Aboyans, Ileana Desormais, Thierry Kowalsky, Jean Pierre Cambou, Joel Constans, Alessandra Bura Rivière.   

Abstract

OBJECTIVE: The aim of the present study was to determine the prevalence of chronic kidney disease (CKD) and its prognostic value in patients hospitalized for lower extremity peripheral artery disease (PAD).
METHODS: Data from the COhorte des Patients ARTériopathes registry, a prospective multicenter, observational study of consecutive patients hospitalized for PAD in academic hospitals of southwestern France, were analyzed. All the subjects were in Rutherford grade ≥ 3, and 55.6% were in grade ≥ 5-6. Associations between CKD and 1-year mortality, as well as amputation rates, were evaluated by Cox analysis. Kaplan-Meier survival curves were analyzed according to estimated glomerular filtration rate (eGFR).
RESULTS: From May 2004 to January 2009, we enrolled 1010 patients. They were classified into four groups according to the eGFR: 21.7% were in group 1 (≥ 90 mL/min per 1.73 m(2)), 34% in group 2 (60-89 mL/min per 1.73 m(2)), 32.2% in group 3 (30-59 mL/min per 1.73 m(2)), and 12.1% in group 4 (<30 mL/min per 1.73 m(2) including dialysis). All-cause mortality was 25.1% at 1 year. The rate of major amputation was 26.3%. Mortality rates were, respectively, at 16%, 18%, 31.7%, and 44.3% (P < .0001) in groups 1 to 4. The major amputation rates were at 23.7%, 21.5%, 28%, and 40.2% (P = .0006), respectively. The presence of severe CKD (group 4) was associated with all-cause mortality (hazard ratio, 1.84; 95% confidence interval, 1.02-3.32; P = .044). In contrast, the risk of amputation was not associated with CKD after adjustments to risk factors.
CONCLUSIONS: The prevalence of CKD in patients hospitalized for PAD is high. CKD is an independent predictor of 1-year mortality, but is not an independent predictor of limb amputation.
Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23769941     DOI: 10.1016/j.jvs.2013.04.007

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

1.  Impact of Chronic Kidney Disease on Clinical Outcomes of Endovascular Treatment for Femoropopliteal Arterial Disease.

Authors:  Paul P Heideman; Mohammad Reza Rajebi; Michael A McKusick; Haraldur Bjarnason; Gustavo S Oderich; Jeremy L Friese; Mark D Fleming; Andrew H Stockland; William S Harmsen; Jay Mandrekar; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2016-06-16       Impact factor: 3.464

2.  Ankle-brachial index and inter-artery blood pressure differences as predictors of cognitive function in overweight and obese older adults with diabetes: results from the Action for Health in Diabetes movement and memory study.

Authors:  Mark A Espeland; Kristen M Beavers; Bethany Barone Gibbs; Karen C Johnson; Timothy M Hughes; Laura D Baker; John Jakicic; Mary Korytkowski; Marsha Miller; George A Bray
Journal:  Int J Geriatr Psychiatry       Date:  2014-12-26       Impact factor: 3.485

3.  Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty.

Authors:  I-Chih Chen; Chao-Chin Yu; Yi-Hsuan Wu; Ting-Hsing Chao
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

4.  Expression of Vascular Cell Adhesion Molecule-1 in Peripheral Artery Disease is Enriched in Patients with Advanced Kidney Disease.

Authors:  Po-Tseng Lee; I-Chuang Liao; Cheng-Han Lee; Ling-Wei Hsu; Ping-Yen Liu
Journal:  Acta Cardiol Sin       Date:  2021-11       Impact factor: 2.672

5.  Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Fabio Manfredini; Nicola Lamberti; Silvia Forcellini; Alda Storari; Massimo Gallerani; Gaetano Caramori; Roberto Manfredini
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

6.  Predictors of early mortality and readmissions among dialysis patients undergoing lower extremity amputation.

Authors:  LaTonya J Hickson; Andrew D Rule; Bjorg Thorsteinsdottir; Raymond C Shields; Ivan E Porter; Mark D Fleming; Daniel S Ubl; Cynthia S Crowson; Kristine T Hanson; Bassem T Elhassan; Rajnish Mehrotra; Shipra Arya; Robert C Albright; Amy W Williams; Elizabeth B Habermann
Journal:  J Vasc Surg       Date:  2018-06-28       Impact factor: 4.268

7.  Indoxyl sulfate impairs angiogenesis via chronic aryl hydrocarbon receptor activation.

Authors:  Zachary R Salyers; Madeline Coleman; Nicholas P Balestrieri; Terence E Ryan
Journal:  Am J Physiol Cell Physiol       Date:  2021-01-06       Impact factor: 4.249

8.  Impact of betablockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease: The COPART Registry.

Authors:  Tristan Mirault; Alexandre Galloula; Jean-Pierre Cambou; Philippe Lacroix; Victor Aboyans; Carine Boulon; Joel Constans; Alessandra Bura-Riviere; Emmanuel Messas
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

9.  Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics.

Authors:  Fabian N Berru; Sarah E Gray; Trace Thome; Ravi A Kumar; Zachary R Salyers; Madeline Coleman; Kerri O'Malley; Leonardo F Ferreira; Scott A Berceli; Salvatore T Scali; Terence E Ryan
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

10.  The impact of chronic kidney disease on outcomes following peripheral vascular intervention.

Authors:  Dennis I Narcisse; Elizabeth Hope Weissler; Jennifer A Rymer; Ehrin J Armstrong; Eric A Secemsky; William A Gray; Jihad A Mustapha; George L Adams; Gary M Ansel; Manesh R Patel; William Schuyler Jones
Journal:  Clin Cardiol       Date:  2020-08-11       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.